Toyonaka, Japan

Yutaka Takeuchi

This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharmaceuticals Company Limited. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yutaka Takeuchi. Retrieved from https://idiyas.com/inventor/yutaka-takeuchi-mc9qtd3s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yutaka Takeuchi: Innovator in Antibiotic Development

Introduction

Yutaka Takeuchi is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic agents. His work has led to advancements that are crucial for medical applications.

Latest Patents

Yutaka Takeuchi holds a patent for a carbapenem compound in crystalline form. This compound, known as (4R,5S,6S 8R,2'S,4'S)-3-[4-(2-Dimethylaminocarbonyl)pyrrolidinylthio]-4-methyl-6-(1-hydroxyethyl)-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid, is recognized for its utility as an antibiotic agent. This innovation is a testament to his expertise in pharmaceutical chemistry.

Career Highlights

Yutaka Takeuchi is associated with Sumitomo Pharmaceuticals Company Limited, where he has been instrumental in research and development. His career reflects a commitment to enhancing healthcare through innovative solutions.

Collaborations

Throughout his career, Yutaka has collaborated with esteemed colleagues, including Yutaka Isobe and Makoto Sunagawa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Yutaka Takeuchi's contributions to antibiotic development highlight his role as a key innovator in the pharmaceutical industry. His patent for a carbapenem compound underscores the importance of his work in advancing medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…